Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Cliniques universitaires Saint-Luc, Brussels

Peter MacCallum Cancer Centre, Melbourne

The Alfred Hospital, Melbourne

Linear Clinical Research, Nedlands

Clinico Y Provincial Barcelona, Barcelona

National Taiwan University Hospital, Taipei

Memorial Sloan Kettering Cancer Center, New York

Institut Paoli-Calmettes, Marseille

University of North Carolina at Chapel Hill, Chapel Hill

Hospital Universitario Fundación Jiménez Díaz, Madrid

Medizinische Hochschule Hanover, Hanover

Institut Claudius Regaud, Toulouse

Centre hospitalier universitaire de Haut Leveque, Pessac

Vanderbilt University Medical Center, Nashville

China Medical University Hospital, Taichung

Hospital Universitario La Fe de Valencia, Valencia

Northwestern University, Chicago

University of Chicago Hospital, Chicago

Centre Hospitalier Lyon Sud, Pierre-Bénite

Hopital Saint Louis, Paris

University of Texas MD Anderson Cancer Center, Houston

UCLA Medical Center, Los Angeles

City of Hope National Medical Center, Duarte

University of California, Davis - Health Systems, Sacramento

National University Cancer Institute, Singapore

Singapore General Hospital, Singapore

Rambam Medical Center, Haifa

H Lee Moffitt Cancer Center, Tampa

Massachusetts General Hospital, Boston

Roswell Park Cancer Institute, Buffalo

BC Cancer Vancouver, Vancouver

Princess Margaret Hospital, Toronto

Jewish General Hospital, Montreal

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul